Retension Pharmaceuticals Ownership & Insider Activity

Retension Pharmaceuticals Inc

RTSNNASDAQ

$15.25

-0.25-1.61%

Last update: Oct 23, 5:20 PM

Retension Pharmaceuticals Ownership & Insider Activity - Benzinga

Retension Pharmaceuticals (RTSN) institutional and insider ownership, recent insider transactions and ownership breakdown.

Net Insider Activity by Month

Purchases (90d)

$370K total

Sales (90d)

Net Activity

Net Buying

Net Value (90d)

$370K

Date	Insider	Title	Type	Shares	Price	Value
Oct 13, 2026	Eric Keller	CHIEF EXECUTIVE OFFICER	BUY	61.830K	$12.00	$250K
Oct 13, 2026	FRANKLIN BERGER	DIRECTOR	BUY	22.517K	$12.00	$120K